← Inner Mongolia Yili Industrial overview

Inner Mongolia Yili Industrial vs Danone SA: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Inner Mongolia Yili Industrial Group Co Ltd (600887.CG)

Q3 2026
▲3▼1

Yili's profit slump offset by buyback and raw milk recovery

  • First-half profit drops 20%, Q2 collapses Yili's first-half net profit fell 20% to 5.76 billion yuan, with second-quarter profit down 84% year-on-year and 93% quarter-on-quarter. Revenue rose 4.1%, but the profit plunge shows margins are under heavy pressure, which weighs on the stock price.

    This is the biggest new negative force on the stock and directly explains why it may be moving down.

  • 1–2 billion yuan buyback for cancellation Yili plans to buy back 1–2 billion yuan of its own shares and cancel them, reducing the number of shares outstanding. This supports the share price by boosting earnings per share and signals management's confidence in the company's future.

    This is a major new positive capital action that directly supports the stock price and offsets the profit miss.

  • Raw milk cycle turning, dairy stocks rally The dairy cow herd is shrinking fast, and raw milk prices are rising in many regions. This supply tightening is starting to reverse the long downcycle, which should improve profits for dairy leaders like Yili as selling prices recover.

    This is a new industry-level driver that could lift Yili's future earnings and explains positive sector sentiment.

  • Yili showcases innovation and data hub at World Dairy Congress Yili hosted the 2026 World Dairy Congress, launched a global dairy data hub, and unveiled ten innovations. This reinforces its industry leadership and long-term technology edge, which can support the stock by improving growth prospects.

    This is a new event that highlights Yili's strategic positioning and innovation, a positive long-term driver.

August 2026
▲3▼1

Yili's profit slump offset by buyback and raw milk recovery

  • First-half profit drops 20%, Q2 collapses Yili's first-half net profit fell 20% to 5.76 billion yuan, with second-quarter profit down 84% year-on-year and 93% quarter-on-quarter. Revenue rose 4.1%, but the profit plunge shows margins are under heavy pressure, which weighs on the stock price.

    This is the biggest new negative force on the stock and directly explains why it may be moving down.

  • 1–2 billion yuan buyback for cancellation Yili plans to buy back 1–2 billion yuan of its own shares and cancel them, reducing the number of shares outstanding. This supports the share price by boosting earnings per share and signals management's confidence in the company's future.

    This is a major new positive capital action that directly supports the stock price and offsets the profit miss.

  • Raw milk cycle turning, dairy stocks rally The dairy cow herd is shrinking fast, and raw milk prices are rising in many regions. This supply tightening is starting to reverse the long downcycle, which should improve profits for dairy leaders like Yili as selling prices recover.

    This is a new industry-level driver that could lift Yili's future earnings and explains positive sector sentiment.

  • Yili showcases innovation and data hub at World Dairy Congress Yili hosted the 2026 World Dairy Congress, launched a global dairy data hub, and unveiled ten innovations. This reinforces its industry leadership and long-term technology edge, which can support the stock by improving growth prospects.

    This is a new event that highlights Yili's strategic positioning and innovation, a positive long-term driver.

Latest
▲3▼1

Yili's profit slump offset by buyback and raw milk recovery

  • First-half profit drops 20%, Q2 collapses Yili's first-half net profit fell 20% to 5.76 billion yuan, with second-quarter profit down 84% year-on-year and 93% quarter-on-quarter. Revenue rose 4.1%, but the profit plunge shows margins are under heavy pressure, which weighs on the stock price.

    This is the biggest new negative force on the stock and directly explains why it may be moving down.

  • 1–2 billion yuan buyback for cancellation Yili plans to buy back 1–2 billion yuan of its own shares and cancel them, reducing the number of shares outstanding. This supports the share price by boosting earnings per share and signals management's confidence in the company's future.

    This is a major new positive capital action that directly supports the stock price and offsets the profit miss.

  • Raw milk cycle turning, dairy stocks rally The dairy cow herd is shrinking fast, and raw milk prices are rising in many regions. This supply tightening is starting to reverse the long downcycle, which should improve profits for dairy leaders like Yili as selling prices recover.

    This is a new industry-level driver that could lift Yili's future earnings and explains positive sector sentiment.

  • Yili showcases innovation and data hub at World Dairy Congress Yili hosted the 2026 World Dairy Congress, launched a global dairy data hub, and unveiled ten innovations. This reinforces its industry leadership and long-term technology edge, which can support the stock by improving growth prospects.

    This is a new event that highlights Yili's strategic positioning and innovation, a positive long-term driver.

Danone SA (BN.PA)

Q3 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

July 2026
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.

Latest
▲4

Danone buys growth brands, beats Q2, strengthens patent

  • Acquires MADE Group and full Australian dairy JV Danone is buying Australia's MADE Group (high-protein drinks, gut-health yoghurts) and the rest of its Australian dairy joint venture. Both add fast-growing health products and are expected to lift profit margins and earnings per share from the first year, supporting the shares.

    A concrete deal that adds growth and profit, directly supporting the stock.

  • Q2 sales beat forecasts, full-year outlook kept Danone's second-quarter sales grew 4.2% versus the 3.7% expected, with specialized nutrition and water (helped by a heatwave) both strong. First-half operating profit and margin came in slightly ahead, and the company kept its full-year growth target, reassuring investors.

    The quarter's results beat expectations and confirm the company is on track.

  • Completes Huel acquisition, expands functional nutrition Danone finished buying Huel, the meal-shake and nutrition brand, adding its direct-to-consumer reach to Danone's global scale. Huel joins the accounts from September 1, 2026, broadening Danone's functional nutrition business and its growth options.

    A completed deal that expands a fast-growing part of the business.

  • New U.S. patent strengthens Akkermansia gut-health IP Danone's subsidiary won a new U.S. patent and favorable rulings protecting its Akkermansia weight-loss ingredient, though appeals continue. Stronger legal protection supports its launch of Akkermansia products in the U.S., Europe and Asia, a potential new sales driver.

    Protects a promising new product line, a real positive for future sales.